Fortress Biotech Inc

General ticker "FBIO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $38.5M

Fortress Biotech Inc does not follow the US Stock Market performance with the rate: -7.5%.

Estimated limits based on current volatility of 2.6%: low 1.70$, high 1.79$

Factors to consider:

  • Current price 33.9% below estimated low
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [4.06$, 11.67$]
  • 2023-12-31 to 2024-12-30 estimated range: [2.74$, 7.77$]

Financial Metrics affecting the FBIO estimates:

  • Negative: Non-GAAP EPS, $ of -17.85 <= 0.10
  • Negative: Operating profit margin, % of -72.88 <= 1.03
  • Negative: Operating cash flow per share per price, % of -76.16 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -24.66 <= 1.31

Similar symbols

Short-term FBIO quotes

Long-term FBIO plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $45.60MM $68.79MM $75.74MM
Operating Expenses $139.87MM $257.33MM $279.31MM
Operating Income $-94.27MM $-188.54MM $-203.56MM
Non-Operating Income $-8.58MM $24.19MM $-9.90MM
Interest Expense $9.70MM $15.31MM $13.64MM
R&D Expense $64.11MM $128.87MM $134.88MM
Income(Loss) $-102.85MM $-164.35MM $-213.46MM
Taxes $0.14MM $0.47MM $0.45MM
Profit(Loss) $-102.98MM $-164.83MM $-213.91MM
Stockholders Equity $100.34MM $108.67MM $41.72MM
Inventory $1.40MM $9.86MM $14.16MM
Assets $333.41MM $396.50MM $294.30MM
Operating Cash Flow $-83.68MM $-116.54MM $-179.40MM
Capital expenditure $7.16MM $16.35MM $3.06MM
Investing Cash Flow $-7.16MM $40.51MM $-22.93MM
Financing Cash Flow $172.41MM $148.99MM $75.32MM
Earnings Per Share* $-21.45 $-30.26 $-36.10

* EPS are Split Adjusted, recent splits may be reflected with a delay.